Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

denotes that the film is still running in theatres. (These numbers and verdict are based only on box office earnings, and the returns do not include any other rights’ [OTT, TV, music ...

denotes that the film is still running in theatres. (These numbers and verdict are based only on box office earnings, and the returns do not include any other rights’ [OTT, TV, music ...